Clinical Trials Directory

Trials / Completed

CompletedNCT06810362

Effects of Aerobic Exercise, Cognitive Remediation and Combined Intervention in Schizophrenia

Walking Our Way to a Healthier Brain: a Randomized Controlled Trial to Evaluate the Effects of Aerobic Exercise, Cognitive Remediation and Combined Intervention in Schizophrenia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Tracking down the efficacy of a combined intervention of cognitive remediation (CR) and phisycal activity (aerobic exercise, AE) in patients diagnosed with schizophrenia

Detailed description

The investigators will address the following objectives: * Primary objective: o assess, through a randomized controlled trial (RCT), the efficacy and feasibility of a combined intervention (CR + AE) in patients with schizophrenia. The primary outcome measure will be cognitive performance, while secondary outcomes will include scales for the assessment of psychopathology, daily functioning, and quality of life. * Secondary objectives: to evaluate changes in bio-physical and laboratory metabolic parameters, as well as in neurotrophic and neuroinflammatory factors. Furthermore, multimodal magnetic resonance imaging (MRI) parameters will be evaluated after the interventions, and their relationship with observed cognitive improvements will be explored.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Remediation (CR)The CR consists of three 1-hour sessions per week of domain-specific computerized exercises, for a period of 12 weeks, totaling 36 hours
BEHAVIORALAerobic ExerciseAerobic exercise consists in two session per week of cycling. Each session lasts for 45 min, with 15 min of warm up pre and post session
OTHERCognitve Remediation + Aerobic ExercisePatients performed both CR exercises and cycling

Timeline

Start date
2019-01-10
Primary completion
2023-09-02
Completion
2023-09-02
First posted
2025-02-05
Last updated
2025-02-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06810362. Inclusion in this directory is not an endorsement.